Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
UNC:FRA
UCB SA
230,50 €
+1,01%
(+2,30) 1D
30 apr, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for UNC...
Açın
223,00 €
High
230,60 €
Low
223,00 €
Mkt. cap
44,44 mlrd
Avg. vol.
17,00
Volume
220,00
Dividend
0,44%
Quarterly dividend
0,25 €
Ex dividend date
4 may 2026
P/E ratio
28,73
52-wk high
285,40 €
52-wk low
148,25 €
EPS
8,02 €
No. of employees
10K
News stories
From sources across the web
Profile
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology. Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
About UCB SA
CEOJean-Christophe Tellier
Employees9,76K
Founded18 yan 1928
Headquarters-
SectorPharmaceutical industry
Websiteucb.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
1,74 mlrd
1,74 mlrd
2,13 mlrd
2,13 mlrd
Cost of goods sold
461,00 mln
461,00 mln
534,00 mln
534,00 mln
Cost of revenue
461,00 mln
461,00 mln
534,00 mln
534,00 mln
Research and development expenses
430,00 mln
430,00 mln
481,00 mln
481,00 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
639,00 mln
639,00 mln
735,50 mln
735,50 mln
Operating expense
935,50 mln
935,50 mln
946,50 mln
946,50 mln
Total operating expenses
1,40 mlrd
1,40 mlrd
1,48 mlrd
1,48 mlrd
Operating income
347,00 mln
347,00 mln
646,50 mln
646,50 mln
Other non operating income
-40,50 mln
-40,50 mln
36,00 mln
36,00 mln
EBT including unusual items
296,50 mln
296,50 mln
614,50 mln
614,50 mln
EBT excluding unusual items
308,00 mln
308,00 mln
622,50 mln
622,50 mln
Income tax expense
59,00 mln
59,00 mln
73,00 mln
73,00 mln
Effective tax rate
19,90%
19,90%
11,88%
11,88%
Other operating expenses
-133,50 mln
-133,50 mln
-270,00 mln
-270,00 mln
Net income
237,50 mln
237,50 mln
541,50 mln
541,50 mln
Net profit margin
13,62%
13,62%
25,46%
25,46%
Earnings per share
-
-
-
-
Interest and investment income
40,00 mln
40,00 mln
-
-
Interest expense
-21,50 mln
-21,50 mln
-58,00 mln
-58,00 mln
Net interest expenses
18,50 mln
18,50 mln
-58,00 mln
-58,00 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
503,50 mln
503,50 mln
803,50 mln
803,50 mln
Gain or loss from assets sale
-
-
1,00 mln
1,00 mln
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer